title: [Effects of peroxisome proliferators PFOA on immune system of mice].
abstract: OBJECTIVE
  To examine the effects of peroxisome proliferators (PP), perfluorooctanoic acid (PFOA), on mouse immune system.
  
  
  METHODS
  Male C57B/6 mice were received the diet containing PFOA and the following parameters were examined, including weight and cell number of thymus and spleen, cell cycle of thymocytes by PI staining, cell phenotype in thymus and spleen by flow cyto metry (FCM) analysis, IgM and IgG production by the protein-A plaque and ELISA assay, and proliferation of splenocytes in response to ConA or LPS by (3)H-TdR labeling.
  
  
  RESULTS
  Severe thymic and splenic atrophy was observed in mice administrated with potent PP, e.g., PFOA. Number of both T and B cells in spleen was decreased upon treatment. Thymocytes were decreased over 90% by treatment, among which the immature CD4(+) CD8(+) population was decreased most dramatically. The most obvious change in thymocytes occurred in the S and G2/M phases. PFOA also prevented the increase both in plaque formation by anti-IgM and -IgG and in serum level of IgM and IgG that normally evoked by immunization with horse red blood cells. Following withdrawal of PFOA from diet, the above parameters rapidly returned to normal.
  
  
  CONCLUSIONS
  Potent PP significantly inhibits mouse immune system.
authors.affiliation: Department of Medical Oncology of the First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China. dryangjin@sina.com
authors.forename: Jin
authors.initials: J
authors.lastname: Yang
authors.forename: Ang
authors.initials: A
authors.lastname: Li
authors.forename: Qian
authors.initials: Q
authors.lastname: Yang
authors.forename: Xu
authors.initials: X
authors.lastname: Li
mesh_terms: D000818:Animals; D001284:Atrophy; D001402:B-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D002210:Caprylates / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D005466:Fluorocarbons / Q000494:pharmacology*; D007107:Immune System / Q000187:drug effects* / Q000276:immunology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism; D020025:Peroxisome Proliferators / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
chemical_list: D002210:Caprylates; D005466:Fluorocarbons; D047492:Peroxisome Proliferator-Activated Receptors; D020025:Peroxisome Proliferators; C023036:perfluorooctanoic acid